A Validated Reversed Phase HPLC Assay for the Determination of Gliclazide in Human Plasma

Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2017, Vol 3, Issue 10

Abstract

Abstract:A simple and precise reversed-phase high performance liquid chromatography (HPLC) method for the determination of gliclazide in human plasma was developed and validated. Using glipizide as an internal standard (IS), separation was achieved on Atlantis dC18 column. The mobile phase consisted of acetonitrile and water (pH= 2.5±0.2 adjusted with phosphoric acid) (55:45, v:v), and delivered at a flow rate of 1 ml/min. 0.5 ml plasma samples were deproteinized with dichloromethane and centrifuged. 100 µl supernatant clear solutions were injected to HPLC system. The eluent was monitored spectrophotometricly at 230 nm. No interference in blank plasma or of commonly used drugs was observed. The relationship between the concentration of gliclazide in plasma and peak height ratio of gliclazide to the IS was linear over the range of 0.05-10.0 μg/ml. Intra-day and inter-day coefficient of variation (CV) and bias were 3.1% to 6.8% and 3.8% to 9.3% respectively. Mean extraction recovery of gliclazide and the IS from plasma samples was 94% and 87% respectively. The method was applied to assess the stability of gliclazide under various conditions generally encountered in the clinical laboratory. Stability for processed and unprocessed samples was ≥ 90% and ≥ 93% respectively. Keywords:Gliclazide, Glipizide, Human plasma, HPLC

Authors and Affiliations

Nada H. Binhashim, Syed N Alvi, Muhammad M. Hammami

Keywords

Related Articles

Bioactive molecules present in Plants play a potential role in the Treatment of Spasticity in Multiple Sclerosis: a new perspective in Future

Abstract: Multiple sclerosis (MS) is a chronic disabling disease of the CNS that affects people during early adulthood. Despite several US FDA-approved medications, the treatment options in MS are limited. Many people wi...

Application of QbD Approach to Development and Validation of a Novel UV- Spectrophotometric Method for Quantitative Estimation of Quetiapine Fumarate in Bulk and Pharmaceutical Formulation (Tablets)

Abstract:Stability Indicating UV-spectrophotometric analytical method validation for the estimation of Quetiapine fumarate have already been reported, but no studies reported so far include the application of Analytical...

Prevalence of Work Related Elbow Pain among Allied Healthcare Providers: A Cross-Sectional Study

Abstract:Musculoskeletal pain is very common complaint in the workplace and about billions of dollars yearly are spending on work related musculoskeletal pain. Elbow pain is one of the common complaints in allied health...

Bisphosphonate induced atypical fractures- The mystery revealed

Abstract: The incidence of atypical fractures associated with prolonged bisphosphonate therapy has increased because of widespread use for treatment of osteoporosis. They can occur following a minimal or no trauma andpre...

Development, Characterization & Comparative Evaluation of Nanostructured Lipid Carriers and Solid Lipid Nanoparticles for Potent Oral Delivery of Furosemide

The aim of the present study was to increase the solubility and thereby improve the oral bioavailability of Furosemide by incorporating the drug in nanostructured lipid carriers (NLC) and in solid lipid nanoparticle (SLN...

Download PDF file
  • EP ID EP393531
  • DOI -
  • Views 109
  • Downloads 0

How To Cite

Nada H. Binhashim, Syed N Alvi, Muhammad M. Hammami (2017). A Validated Reversed Phase HPLC Assay for the Determination of Gliclazide in Human Plasma. Saudi Journal of Medical and Pharmaceutical Sciences, 3(10), 1128-1132. https://europub.co.uk./articles/-A-393531